Maynard Um
-
-
-
-
-
-
-
Immunocore Holdings (IMCR) PT Raised to $34 at Jefferies
-
-
-
-
-
-
-
UBS Assumes Immunocore Holdings (IMCR) at Buy
-
-
-
-
-
-
-
Immunocore Holdings plc (IMCR) Misses Q2 EPS by 2c
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Immunocore Holdings (IMCR)
-
-
-
-
-
-
-
Immunocore (IMCR) announces treatment of first patient in the Phase 1/2 trial of IMC-R117C targeting PIWIL1 in advanced gastrointestinal cancers
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Immunocore Holdings (IMCR)
-
-
-
-
-
-
-
Immunocore Holdings plc (IMCR) Tops Q2 EPS by 25c
469,699 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


